Citadel Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $457M | Sell |
1,562,219
-105,850
| -6% | -$34.8M | 0.07% | 199 |
|
|
2025
Q4 | $585M | Buy |
1,668,069
+1,244,783
| +294% | +$421M | 0.09% | 153 |
|
|
2025
Q3 | $137M | Buy |
+423,286
| New | +$132M | 0.02% | 661 |
|
|
2025
Q2 | – | Sell |
-218,689
| Closed | -$88M | – | 13159 |
|
|
2025
Q1 | $95.1M | Buy |
218,689
+78,755
| +56% | +$31.6M | 0.02% | 729 |
|
|
2024
Q4 | $51.6M | Buy |
139,934
+56,744
| +68% | +$23.7M | 0.01% | 1242 |
|
|
2024
Q3 | $43.3M | Buy |
+83,190
| New | +$44.4M | 0.01% | 1358 |
|
|
2024
Q2 | – | Sell |
-13,565
| Closed | -$7.17M | – | 14515 |
|
|
2024
Q1 | $7.03M | Sell |
13,565
-362,901
| -96% | -$180M | ﹤0.01% | 3435 |
|
|
2023
Q4 | $178M | Buy |
376,466
+126,771
| +51% | +$58.6M | 0.04% | 393 |
|
|
2023
Q3 | $109M | Sell |
249,695
-75,222
| -23% | -$34.1M | 0.02% | 596 |
|
|
2023
Q2 | $144M | Sell |
324,917
-36,970
| -10% | -$17.1M | 0.03% | 439 |
|
|
2023
Q1 | $166M | Sell |
361,887
-219,308
| -38% | -$104M | 0.04% | 398 |
|
|
2022
Q4 | $298M | Buy |
581,195
+392,973
| +209% | +$200M | 0.07% | 204 |
|
|
2022
Q3 | $85.5M | Sell |
188,222
-33,598
| -15% | -$16.1M | 0.02% | 687 |
|
|
2022
Q2 | $107M | Sell |
221,820
-46,538
| -17% | -$23M | 0.03% | 542 |
|
|
2022
Q1 | $132M | Sell |
268,358
-33,004
| -11% | -$15.1M | 0.03% | 527 |
|
|
2021
Q4 | $140M | Buy |
301,362
+287,125
| +2,017% | +$121M | 0.03% | 495 |
|
|
2021
Q3 | $5.31M | Buy |
14,237
+1,536
| +12% | +$584K | ﹤0.01% | 4182 |
|
|
2021
Q2 | $4.85M | Sell |
12,701
-123,340
| -91% | -$47.1M | ﹤0.01% | 4511 |
|
|
2021
Q1 | $48.8M | Sell |
136,041
-51,728
| -28% | -$16.6M | 0.01% | 1060 |
|
|
2020
Q4 | $60.3M | Buy |
187,769
+138,207
| +279% | +$42.4M | 0.02% | 825 |
|
|
2020
Q3 | $13.3M | Sell |
49,562
-565,382
| -92% | -$152M | ﹤0.01% | 1965 |
|
|
2020
Q2 | $162M | Buy |
614,944
+380,523
| +162% | +$102M | 0.06% | 232 |
|
|
2020
Q1 | $53.2M | Sell |
234,421
-23,664
| -9% | -$6.45M | 0.02% | 611 |
|
|
2019
Q4 | $77.9M | Buy |
258,085
+223,576
| +648% | +$61.5M | 0.03% | 522 |
|
|
2019
Q3 | $8.29M | Sell |
34,509
-130,172
| -79% | -$35.7M | ﹤0.01% | 2450 |
|
|
2019
Q2 | $46.5M | Sell |
164,681
-85,409
| -34% | -$23.3M | 0.02% | 768 |
|
|
2019
Q1 | $71.8M | Sell |
250,090
-55,977
| -18% | -$16.2M | 0.04% | 517 |
|
|
2018
Q4 | $80.4M | Sell |
306,067
-320,468
| -51% | -$88.1M | 0.04% | 405 |
|
|
2018
Q3 | $172M | Sell |
626,535
-507,626
| -45% | -$132M | 0.08% | 222 |
|
|
2018
Q2 | $270M | Buy |
1,134,161
+1,052,083
| +1,282% | +$244M | 0.13% | 93 |
|
|
2018
Q1 | $18M | Buy |
82,078
+37,380
| +84% | +$8.78M | 0.01% | 1206 |
|
|
2017
Q4 | $10.1M | Sell |
44,698
-153,107
| -77% | -$32.6M | 0.01% | 1726 |
|
|
2017
Q3 | $37.6M | Buy |
197,805
+80,211
| +68% | +$15.3M | 0.03% | 697 |
|
|
2017
Q2 | $22.1M | Sell |
117,594
-175,278
| -60% | -$31.5M | 0.02% | 941 |
|
|
2017
Q1 | $48.4M | Buy |
292,872
+65,341
| +29% | +$10.4M | 0.04% | 468 |
|
|
2016
Q4 | $32.7M | Buy |
227,531
+24,243
| +12% | +$3.25M | 0.03% | 580 |
|
|
2016
Q3 | $25.5M | Buy |
203,288
+162,351
| +397% | +$21M | 0.03% | 731 |
|
|
2016
Q2 | $5.38M | Sell |
40,937
-53,364
| -57% | -$7.3M | 0.01% | 1758 |
|
|
2016
Q1 | $13.1M | Sell |
94,301
-399,599
| -81% | -$53.4M | 0.02% | 1013 |
|
|
2015
Q4 | $68.9M | Buy |
493,900
+338,619
| +218% | +$46.6M | 0.08% | 282 |
|
|
2015
Q3 | $21.7M | Buy |
155,281
+86,854
| +127% | +$13.1M | 0.02% | 842 |
|
|
2015
Q2 | $11.2M | Buy |
+68,427
| New | +$10.9M | 0.01% | 1391 |
|
|
2015
Q1 | – | Sell |
-1,103,002
| Closed | -$157M | – | 8596 |
|
|
2014
Q4 | $139M | Sell |
1,103,002
-316,326
| -22% | -$39.1M | 0.14% | 113 |
|
|
2014
Q3 | $170M | Buy |
1,419,328
+328,927
| +30% | +$37.7M | 0.18% | 88 |
|
|
2014
Q2 | $117M | Sell |
1,090,401
-528,438
| -33% | -$54.4M | 0.13% | 133 |
|
|
2014
Q1 | $161M | Buy |
1,618,839
+1,136,918
| +236% | +$103M | 0.19% | 79 |
|
|
2013
Q4 | $44.5M | Buy |
481,921
+157,538
| +49% | +$14M | 0.06% | 405 |
|
|
2013
Q3 | $27.1M | Buy |
324,383
+254,205
| +362% | +$21.8M | 0.04% | 576 |
|
|
2013
Q2 | $5.74M | Buy |
+70,178
| New | +$5.25M | 0.01% | 1452 |
|
Other funds holding ELV
VCM
VPM
Citadel Advisors's ELV Position: Q1 2026 in Review
Citadel Advisors reduced its Elevance Health (ELV) stake by 6.3% in Q1 2026, selling an estimated $34.8M and leaving 1,562,219 shares worth $457M. The position accounts for 0.07% of the portfolio, ranked #199.
Citadel Advisors first reported a position in ELV in Q2 2013 and has held it in 49 quarters since. The position peaked at $585M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Citadel Advisors held 1,562,219 shares of Elevance Health worth $457M as of Q1 2026.
- Citadel Advisors sold 105,850 Elevance Health shares in Q1 2026, an estimated $34.8M.
- Elevance Health made up 0.07% of Citadel Advisors's portfolio in Q1 2026, its #199 holding.
- Citadel Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 49 quarters since.
- Citadel Advisors's Elevance Health position peaked at $585M in Q4 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.